Global Cell Culture Market Size By Product (Equipment, Consumables), By Application (Diagnostics, Biopharmaceutical Production), By End User (Hospitals and Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies), By Geographic Scope And Forecast

Cell Culture Market Valuation – 2024-2031

Increasing prevalence of epidemiology and chronic diseases such as HPV, HIV, and others are surging the demand for production of vaccine and biopharmaceuticals. In response to this, there is a huge demand for substrates for culturing of viruses to produce monoclonal antibodies and vaccines. This is likely to bolster the growth of the Cell Culture Market. According to the analyst from Market Research, the Cell Culture Market is estimated to reach a valuation of USD 56.2 Billion over the forecast 2031, by subjugating the revenue of USD 24.92 Billion valued in 2023.

The acceleration in the integration of biotechnological advancements, especially healthy substrates, for culturing of animal, microbial, and plant cells,  supporting innovation in biopharmaceuticals and regenerative medicine is enabling the market to grow at a CAGR of 10.7% from 2024 to 2031.

Cell Culture MarketDefinition/ Overview

Cell culture is the process of growing cells in vitro, which offers an artificial environment for healthy growth instead of their natural habitat. Growing demand for production of biopharmaceuticals and regenerative medicine is increasing the demand for cells. This opportunity is projected to bolster the adoption of cell culturing solutions over the forecast period.

The cell culture are designed to artificially offer optimal natural parameters, such as nutrition, temperature, and gasses for enhanced cell growth and proliferation.. Cell culture is frequently used in a variety of scientific and industrial applications, including cellular behavior research, drug discovery, biotechnology, and vaccine and medicinal protein synthesis.

The development of 3D cell cultures offered more realistic resemblance to in vivo models for enabling research and development activities on cellular behavior, pharmacological responses, and diagnosis of diseases.

Will demand for biopharmaceuticals favor the expansion of the Cell Culture Market?

Increased emphasis on personalized treatment and biopharmaceuticals such as blood factors, vaccines, and monoclonal antibodies is resulting in fueling the application of cell culture in the biotechnology sector. Additionally, the technological breakthroughs in cell culture, such as 3D cell culture and use of microfluidic devices, are all anticipated to have a positive influence on the Cell Culture Market. Thus, growing emphasis on customizing healthcare solutions along with the advancements in biotechnology sector is supporting the growth of the Cell Culture Market.

Rising competition among the drug developers to tackle the prevalent chronic illnesses is bolstering the demand for accurate and efficient testing  of toxicity, drug potency, and other factors. Thus, the development of drugs is proving opportunistic for the current market.

Increasing incidences of certain incurable diseases such as cancer, HIV, and autoimmune diseases is shifting the preference of medical professionals toward gene therapy and stem cell treatments. The spurring demand for such innovative treatments is likely to encourage the application of sing-use bioreactors for improving the technique of cell culturing, driving the growth of the Cell Culture Market.

Additionally, increasing government funding and support for on-going research and development in the field of cytology is projected to have a potential influence on cell culture industry. Moreover, the growing demand for personalized medicines and innovative treatments to combat the ongoing spree of diseases is initiating the healthcare and government authorities to spread awareness regarding the benefits of cell culture for the medical industry.

Will Lack of Standardization and High Costs hinder the Cell Culture Market?

Lack of standardized protocols or techniques across different laboratories is resulting in variation  in experimental outcomes. Thereby, inhibiting the adoption of cell culture across the healthcare sector, posing a huge challenge for the growth of the Cell Culture Market.

Rising need for sterilized products, well-equipped laboratories, sterilization protocols, and sterile environment are some of the variables resulting in  an increase  in the laboratory expenditure. This upfront cost in the setting up of aseptic environment with ambient temperature for culturing of cells is likely to restrain the adoption of cell culture techniques.

Besides these, the sales of cell culture are primarily affected by the rising ethical concerns regarding the use of fetal bovine serum (FBS). The exploitative character of FBS that is hurting new born calve and also the high possibility of  possible spreading  prions and animal viruses is presenting a huge difficulty for its acceptance.

Category-Wise Acumens

Which Product Segment Holds the Largest Share in the Cell Culture Market?

According to Analysis, the consumables segment is estimated to hold the top position in the product segment during the forecast period. Increased demand for cell culture and focus on cost-effectiveness are the major elements in enabling consumables dominate the product segment.

The rising prevalence of chronic diseases is bolstering the demand for efficient personalized treatment and biological medical products for better patient outcome. It is the demand for complete cure that is  driving up demand for consumables. Also, the development of 3D cell culture models, microfluidic devices, and organ-on-a-chip technologies are examples of ongoing technical breakthroughs that call for the use of specialist consumables designed for these complex systems.

Furthermore, the changing regulatory landscape has a significant impact on the continual improvement and adaption of cell culture consumables to meet demanding industry standards.

How will the Biopharmaceutical Application Boost the Sales of the Cell Culture Market?

The biopharmaceutical production application segment is estimated to dominate the Cell Culture Market during the forecast period. On-going research and development in the field of biopharmaceuticals is facilitating the production of effective  monoclonal antibodies and vaccines for curbing the spread of life-threatening diseases. This demand is resulting in the booming of biopharmaceutical segment.

Along with strong governmental support and funding for the development of infrastructural facilities and innovations of cell culture in emerging applications is likely to benefit the biopharmaceutical segment growth..

In addition to this, growing demand for complete aseptic conditions and efficient equipment such as bioreactors and 3D culture systems is creating a suitable environment for the development of biopharmaceuticals, spurring continued investment and expansion.

How will demand for Cell Cultures in North America impact the Cell Culture market?

According to analyst, North America is estimated to dominate the Cell Culture Market during the forecast period. Growing biopharmaceutical industry, Strong R&D infrastructure, and Government support are major factors influencing growth in North America. A highly skilled workforce with expertise in cell culture techniques adds to the region’s strength. North America’s dominance in the cell culture sector is cemented by a sizable pool of scientists and technicians as well as a steady stream of talent brought in by a strong focus on STEM education.

Large industry players like Pfizer, Genentech, and Amgen are part of the region’s well-established and developed biotechnology and pharmaceutical sectors. Because they actively spend in research and development and use cell culture extensively for drug discovery, development, and biopharmaceutical production, these firms are crucial in driving demand for cell culture-related consumables, equipment, and services.

How will the Rapid Expansion of Biotechnology Influence the Opportunities for Cell Cultures in Asia Pacific?

Asia Pacific is estimated to be the most opportunistic region for the cell cultures market during the forecast period. Increasing aggression for early adoption of cutting-edge technologies including organ-on-a-chip technology, microfluidics, and 3D bioprinting in this region is projected to offer new opportunities of growth for the Cell Culture Market.

The unhygienic conditions and low income for health checkup are resulting in the emergence of deadly diseases in the heavily populated and poverty struck economies such as Meghalaya, China, India, and Pakistan. This unhealthy condition is creating a  market for innovations in the flourishing cell culture industry in this region.

Booming biotechnology sector in Asia Pacific is turning this region into a potential ground for customized treatments such as gene therapy, and biopharmaceutical production. Thereby, enabling the Cell Culture Market experience rapid growth in region. The practice of advantages such as favorable reimbursement policies and supportive government-initiated programs in this emerging nation are responsible in the emergence of pool of qualified researchers and engineers. All these factors are enabling Asia Pacific exhibit rapid growth.

Global Cell Culture Market Segmentation Analysis

The Global Cell Culture Market is segmented on the basis of Product, Application, End User, And Geography.

Cell Culture Market, By Product

• Consumables
  1. Media
  2. Sera
  3. Reagents
• Equipment
  1. Incubators
  2. Centrifuges
  3. Pipetting Instruments
  4. Biosafety Equipment
  5. Cryostorage Equipment

Based on Product, The market is segmented into Consumables and Equipment. The Consumable segment is further sub-segmented into Media, Sera, and Reagents, whereas the Equipment segment is further classified into Incubators, Centrifuges, Pipetting Instruments, Biosafety Equipment, and Cryostorage Equipment. The Consumable segment dominated the Global Cell Culture Market and held the largest market share in 2021. Almost every type of vessels such as tubes and pipettes is commercially available for single use. In addition to this, there is a huge requirement for reagents for cell culture. Therefore, repeated purchase of consumables for cell culture research purposes is one of the key factors which is contributing to the highest market share of the segment.

Cell Culture Market, By Application

• Diagnostics
• Biopharmaceutical Production
• Tissue Engineering & Regenerative Medicine
• Drug Screening & Development
• Others

Based on Application, The market is segmented into Diagnostics, Biopharmaceutical Production, & , & Development, and Others. The Biopharmaceutical Production segment held the major market share in the year 2021. A growing preference for biopharmaceuticals over conventional medicines is driving the production of biopharmaceuticals across the globe. Furthermore, the increased popularity of biosimilars in the world further propels the demand for cell cultures.

Cell Culture Market, By End User

• Hospitals & Diagnostic Laboratories
• Pharmaceutical & Biotechnology Companies
• Research & Academic Institutes
• Other End Users

Based on End User, The market is segmented into Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Other End Users. The Research & Academic Institutes are predicted to grow at the highest CAGR in the Global Cell Culture Market over the forecast period. The cell culture system is increasingly being used in the research and academic industry across the globe. Increasing research on various diseases such as cancer, rare diseases, and chronic diseases is driving the demand for cell culture across research institutes.

Cell Culture Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Regional Analysis, The Global Cell Culture Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region accounted for the largest market share in the Global Cell Culture Market. The presence of a large number of key players across the countries such as the U.S. and Canada is significantly contributing to the growth of the market. Furthermore, highly developed healthcare infrastructure across the region further boosts the market’s growth. On the other hand, the Asia Pacific region is anticipated to grow at the highest growth rate over the forecast period. Increasing biopharmaceutical research in the region has led to the rise of this industry.

Key Players

The “Global Cell Culture Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Thermo Fisher Scientific, Inc., Corning Incorporated, Danaher Corporation, Getinge AB, FUJIFILM Irvine Scientific, Inc., Miltenyi Biotec, Agilent Technologies, Inc, Becton, Dickinson and Company, Eppendorf AG, Hi-Media Laboratories, Merck KGAA, GE Healthcare, Lonza Group AG, Sartorius AG, Promocell GmbH, Takara Bio Inc., Charles River Laboratories International Inc., Cyfuse Biomedical, Vericel Corporation, BD Biosciences, MilliporeSigma, STEMCELL Technologies, Incucyte, Organovo, Astute Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In October 2023, Thermo Fisher and Lonza announced a collaboration to create a scalable cell culture manufacturing platform for biopharmaceutical production. This platform will bring together Lonza’s cell line development and manufacturing skills with Thermo Fisher’s automation and bioprocessing experience.
• In October 2023, Cytiva acquired Cevec Pharmaceuticals, to bolster its biomanufacturing solutions portfolio. Cell line and process development for the manufacturing of biopharmaceuticals is Cevec’s area of expertise. With this purchase, Cytiva can better meet the increasing need for effective biopharmaceutical research and manufacturing by broadening its capabilities and using its experience in cell culture and bioprocessing.
• In October 2023, Sartorius unveiled its BIOFLOATTM 96-well plates, which are intended for spheroids culture that do not include surface-attached cells. This technique benefits tissue engineering and cancer research by streamlining spheroid culture and enhancing its viability and function.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our <a href="https//www.marketresearch.com/contact